Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery

JAMA - Journal of the American Medical Association

Volumn 313, Issue 21, 2015, Pages 2162-2171

  Schweizer, Marin L ^a,b,c   Chiang, Hsiu Yin ^a   Septimus, Edward ^d,e   Moody, Julia ^d   Braun, Barbara ^f   Hafner, Joanne ^f   Ward, Melissa A ^a   Hickok, Jason ^d   Perencevich, Eli N ^a,b   Diekema, Daniel J ^a   Richards, Cheryl L ^f   Cavanaugh, Joseph E ^c   Perlin, Jonathan B ^d   Herwaldt, Loreen A ^a,c,g  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d HOSPITAL CORPORATION OF AMERICA   (United States)

^e TEXAS A AND M UNIVERSITY   (United States)

^f Joint Commission   (United States)

^g UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CEFAZOLIN; CEFUROXIME; CHLORHEXIDINE GLUCONATE; CREATININE; GLUCOSE; PSEUDOMONIC ACID; VANCOMYCIN; CHLORHEXIDINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CHARLSON COMORBIDITY INDEX; DIABETES MELLITUS; FEMALE; HEART SURGERY; HIP ARTHROPLASTY; HIP SURGERY; HUMAN; INTERVENTION STUDY; KIDNEY DISEASE; KNEE ARTHROPLASTY; KNEE SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NEOPLASM; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SKIN IRRITATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; UNITED STATES; VERY ELDERLY; ADOLESCENT; ANALOGS AND DERIVATIVES; ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; DRUG COMBINATION; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; NOSE; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CARDIAC SURGICAL PROCEDURES; CEFAZOLIN; CEFUROXIME; CHLORHEXIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MUPIROCIN; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VANCOMYCIN; YOUNG ADULT;

EID: 84930468773     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.5387     Document Type: Article

References (36)

1. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery.J Infect Dis. 1995;171(1):216-219.
2. Perl TM, Cullen JJ, Wenzel RP, et al Mupirocin And The Risk Of Staphylococcus Aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346(24):1871-1877.
3. Kalra L, Camacho F, Whitener CJ, et al. Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization.Am J Infect Control. 2013;41(12):1253-1257.
4. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. JHospInfect. 1995;31(1):13-24.
5. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17.
6. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin vs cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123(2):326-332.
7. Tyllianakis ME, Karageorgos ACh, Marangos MN, Saridis AG, Lambiris EE. Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and 2 specific antistaphylococcal agents. J Arthroplasty. 2010;25(7):1078-1082.
8. Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743.
9. Kline S, Highness M, Herwaldt LA, Perl TM. Variable screening and decolonization protocols for Staphylococcus aureus carriage prior to surgical procedures. Infect Control Hosp Epidemiol. 2014;35(7):880-882.
10. Diekema D, Johannsson B, Herwaldt L, et al. Current practice in Staphylococcus aureus screening and decolonization. Infect Control Hosp Epidemiol. 2011;32(10):1042-1044.
11. Berríos-Torres SI, Yi SH, Bratzler DW, et al. Activity of commonly used antimicrobial prophylaxis regimens against pathogens causing coronary artery bypass graft and arthroplasty surgical site infections in the United States, 2006-2009. Infect Control Hosp Epidemiol.2014;35(3):231-239.
12. Anderson DJ, Chen LF, Sexton DJ, Kaye KS. Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting. Infect Control Hosp Epidemiol. 2008;29(10):941-946.
13. Braun BI, Herwaldt L, Schweizer M, et al. Development and implementation of a consensus algorithm to optimize preoperative antimicrobial prophylaxis and decrease gram-positive surgical site infections for cardiac and orthopedic procedures. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-hai/hai-article3.html. Accessed May 6, 2015.
14. Zwarenstein M, Treweek S, Gagnier JJ, et al; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
15. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464-475.
16. Bratzler DW, Dellinger EP, Olsen KM, et al American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283.
17. Sievert DM, Ricks P, Edwards JR, et al National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobialresistant pathogens associated with health care-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol.2013;34(1):1-14.
18. Centers for Disease Control and Prevention National Healthcare Safety Network. Surgical site infection (SSI) event. http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Accessed August 15, 2014.
19. Roy MC. Modern approaches to preventing surgical site infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:369.
20. Lankiewicz JD, Yokoe DS, Olsen MA, et al. Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? Infect Control Hosp Epidemiol. 2012;33(2):202-204.
21. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. http://simpleshowoflove.weebly.com/uploads/1/4/0/7/14073276/agar-dilution-assay.pdf. Accessed May 6, 2015.
22. Palepou MF, Johnson AP, Cookson BD, Beattie H, Charlett A, Woodford N. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother. 1998;42(5): 577-583.
23. McDanel JS, Murphy CR, Diekema DJ, et al. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother. 2013;57(1):552-558.
24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
25. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project net (HCUPnet) website. http://hcupnet.ahrq.gov/. Accessed April 15, 2014.
26. Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS. Costs associated with surgical site infections in Veterans Affairs hospitals. JAMA Surg. 2014;149(6):575-581.
27. Taylor GJ, Mikell FL, Moses HW, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol. 1990;65(5):309-313.
28. Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SR. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2012;33(2):152-159.
29. The Joint Commission. Specifications Manual for Joint Commission National Quality Core Measures (2010B). https://manual.jointcommission.org/releases/archive/TJC2010B1/DataElem0133.html. Accessed July 17, 2014.
30. Engelman R, Shahian D, Shemin R, et al Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg. 2007;83(4):1569-1576.
31. Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. JHospInfect. 2013;85(4):249-256.
32. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis. 2009;48(7):922-930.
33. Immerman I, Ramos NL, Katz GM, Hutzler LH, Phillips MS, Bosco JA III. The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.J Arthroplasty. 2012;27(6):870-876.
34. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
35. Haynes AB, Weiser TG, Berry WR, et al Safe Surgery Saves Lives Study Group. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360(5):491-499.
36. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004;38(11):1586-1591.